Wu Ahua, Guo Zhinan, Lin Yilan, Chi Jiahuang, Lan Yanqi, Lou Qun, Zhang Haixia, Chen Youlan
Xiamen City Center for Disease Control and Prevention, Xiamen, Fujian, China.
Xiamen City Center for Disease Control and Prevention, Xiamen, Fujian, China.
Cancer Epidemiol. 2025 Feb;94:102718. doi: 10.1016/j.canep.2024.102718. Epub 2024 Nov 29.
Gastric cancer remains one of the most common cancers and the leading cause of death in China. This study aims to describe the incidence, mortality, survival rates, and their changing trends of gastric cancer in Xiamen, China from 2011 to 2020.
Population-based cancer registry data were used to calculate the incidence, mortality, and survival rates of gastric cancer. The study population consisted of gastric cancer patients diagnosed from January 1, 2011, to December 31, 2020, and followed up until September 30, 2023. The relative survival of gastric cancer was calculated using period methods. The change in trends was analyzed using Joinpoint regression.
From 2011-2020, a total of 4716 new cases of gastric cancer and 3520 related deaths were reported. The crude incidence rate and age-standardized incidence rate (ASIR) were 21.82/100,000 and 16.74/100,000. The crude mortality rate and age-standardized mortality rate (ASMR) were 16.29/100,000 and 12.30/100,000. The ASIR and ASMR in males (ASIR: 24.71/100,000, ASMR: 18.75/100,000) were both more than those in females (ASIR: 9.6/100,000, ASMR: 6.55/100,000). The observed 5-year survival rate was 25.83 %, with an age standardized survival of 27.60 %. The incidence and mortality of gastric cancer showed a decreasing trend, and the 5-year ARS between 2016 and 2020 (30.03 %, 95 %CI: 28.07-32.12 %) was higher than between 2011 and 2015 ( 24.79 %, 95 %CI: 22.53-27.27 %). Furthermore, the survival rate decreased with increasing age.
From 2011-2020, the incidence and mortality of gastric cancer in Xiamen City have shown a decreasing trend, and the survival rate has significantly improved. Despite improved survival, the 5-year ARS remains low.
胃癌仍然是中国最常见的癌症之一,也是主要的死亡原因。本研究旨在描述2011年至2020年中国厦门胃癌的发病率、死亡率、生存率及其变化趋势。
基于人群的癌症登记数据用于计算胃癌的发病率、死亡率和生存率。研究人群包括2011年1月1日至2020年12月31日诊断为胃癌的患者,并随访至2023年9月30日。采用期间法计算胃癌的相对生存率。使用Joinpoint回归分析趋势变化。
2011 - 2020年,共报告4716例胃癌新发病例和3520例相关死亡病例。粗发病率和年龄标准化发病率(ASIR)分别为21.82/10万和16.74/10万。粗死亡率和年龄标准化死亡率(ASMR)分别为16.29/10万和12.30/10万。男性的ASIR和ASMR(ASIR:24.71/10万,ASMR:18.75/10万)均高于女性(ASIR:9.6/10万,ASMR:6.55/10万)。观察到的5年生存率为25.83%,年龄标准化生存率为27.60%。胃癌的发病率和死亡率呈下降趋势,2016年至2020年的5年年龄标准化相对生存率(30.03%,95%CI:28.07 - 32.12%)高于2011年至2015年(24.79%,95%CI:22.53 - 27.27%)。此外,生存率随年龄增长而降低。
2011 - 2020年,厦门市胃癌的发病率和死亡率呈下降趋势,生存率显著提高。尽管生存率有所改善,但5年年龄标准化相对生存率仍然较低。